logo
Ashish Kacholia to buy additional shares in smallcap stock; up 51% in 1 mth

Ashish Kacholia to buy additional shares in smallcap stock; up 51% in 1 mth

Man Industries share price today: Shares of Man Industries (India) rallied 12 per cent to hit an eight-month high of ₹405.35 on the BSE in Monday's intra-day trade. This comes after the company's board approved fundraising of up to ₹300 crore through the issuance of convertible warrants to the promoter group and equity shares to a non-promoter group, through a preferential issue.
The stock price of a small-cap iron & steel company is trading at its highest level since September 2024. In the past month, it has outperformed the market by surging 51 per cent, as compared to a 1 per cent rise in the BSE Sensex.
Ashish Kacholia's, Vikas Khemani's stake in Man Industries
Investors Ashish Kacholia (2.03 per cent) and Vikas Vijaykumar Khemani (2.44 per cent), collectively held a 4.47 per cent stake in Man Industries as on May 28, 2025, the shareholding pattern data showed.
Conversion of warrants by promoter
The Allotment Committee of the board of directors of the Company at its meeting held on May 28, 2025, has inter alia considered and approved the allotment of 2.5 million equity shares of face value ₹5 each, upon exercise of the conversion option by Man Finance Private Limited, a Promoter Group entity, in respect of 2.5 million warrants allotted to them by the Board of Directors on December 1, 2023.
Board approves ₹300 crore fundraise
The board of directors of Man Industries at its meeting held on Saturday, May 31, 2025, inter alia, considered and approved the raising of funds through the issuance of convertible warrants to the promoter group and equity shares to non promoter group, through preferential issue, to raise an amount up to ₹ 300 crore.
The board approved issue, offer and allot up to 7.93 million equity shares of face value ₹5 each for cash at a price of ₹328 per equity share for an amount up to ₹260 crore to the non-promoters, on a preferential basis, subject to the approval of shareholders of the company.
Man Industries Q4 results
Man Industries on May 12, 2025, said that the company delivered its highest-ever revenue, earnings before interest, taxes, depreciation and amortisation (Ebitda), and profit after tax (PAT) on both quarterly and annual bases. The company posted a 45 per cent year-on-year (Y-o-Y) growth in PAT in the financial year 2024-25 (FY25), reflecting robust operational efficiency and the successful execution of strategic initiatives across key domestic and international markets.
In the January to March 2025 quarter (Q4FY25), Man Industries' consolidated PAT more than doubled to ₹40.3 crore, against ₹17.2 crore in Q4FY24. Ebitda grew 56.6 per cent YoY at ₹101.60, and margins improved 330 bps to 11.4 per cent. Revenue from operations climbed 9.3 per cent YoY to ₹850.4 crore from ₹778.10 crore in the year-ago quarter.
The management said the company's growth momentum is driven by strategic initiatives aimed at expanding capacity, diversifying revenue streams, strengthening market presence, and sharpening its focus on core business operations.
Order Book
As of FY25-end, the company holds an executable order book of ₹2,500 crore for fulfilment over the next 6–12 months, with a total bid book of ₹15,000 crore, indicating strong demand visibility and revenue growth potential.
Outlook
Man Industries said the company is targeting a ~20 per cent YoY revenue growth for FY26, backed by the timely execution of ongoing and upcoming projects, capacity expansion, and continued order inflows. With a strategic emphasis on operational excellence, product innovation, and international market expansion, Man Industries is well-positioned to deliver sustained value to all stakeholders, the management said.
'Our targeted expansions into the ERW segment, successful execution of high-value projects, robust order book, and the strategic monetisation of a non-core asset have laid a strong foundation for continued momentum in FY26. With capacity expansions progressing in Saudi Arabia and Jammu, we are confident in our ability to scale operations and deepen our footprint across domestic and global markets,' the management said.
About Man Industries
Man Industries is one of the largest manufacturers and exporters of large diameter carbon steel line pipes (LSAW, HSAW and ERW), which are used for various high-pressure transmission applications for the oil & gas industry, petrochemicals, water, dredging & fertilisers, hydro-carbon and CGD Sector.
The company is undertaking capex to further widen its product offerings by entering the manufacturing of Stainless-Steel Seamless pipes and setting up a new plant at Dammam, Saudi Arabia, with a cost of ₹ ~600 crore. This plant will include line pipe manufacturing and a coating facility, which will cater to Saudi Arabia's growing demand.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Max Healthcare Q1 profit up 17 pc at  ₹345 cr
Max Healthcare Q1 profit up 17 pc at  ₹345 cr

Mint

time19 minutes ago

  • Mint

Max Healthcare Q1 profit up 17 pc at ₹345 cr

New Delhi, Aug 13 (PTI) Max Healthcare Institute on Wednesday said its profit after tax increased 17 per cent year-on-year to ₹ 345 crore for June quarter FY26 on enhanced utilisation of operational beds across the hospital network. The healthcare major reported a profit after tax (PAT) of ₹ 295 crore in the April-June period last year. Gross revenue rose to ₹ 2,574 crore in the quarter from ₹ 2,028 crore in the year-ago period, Max Healthcare said in a statement. Net debt at June-end stood at ₹ 1,755 crore as compared with ₹ 1,576 crore on March 31, 2025. The company said its board has approved execution of an agreement to lease a built-to-suit 130-bed hospital in Dehradun. The proposed facility will be located near the company's existing 220-bed hospital, which is operational since 2012. Scheduled for commissioning in 2028, the new hospital will, among other specialties, focus on advanced oncology services, including radiation therapy, it said. Besides, Jaypee Healthcare Ltd, a wholly-owned subsidiary, has executed a binding term sheet to divest Chitta (Bulandshahr) and Anoopshahr hospitals to Manush Aushadi and Anusandan Ltd for ₹ 40 crore, subject to working capital adjustment at closing. This move is in line with the company's strategy to concentrate on super-specialty care in larger cities, it said. "Our sustained growth is a reflection of our strategy and execution capabilities," Max Healthcare Institute Chairman and Managing Director Abhay Soi said. The commissioning of 160-bed brownfield tower at Max Mohali, along with additional brownfield capacities coming online at Max Smart and Nanavati-Max shortly, will significantly enhance clinical and financial performance of the network, he added. "In parallel, we are scaling up our clinical and support teams, while optimizing our service mix to ensure rapid and effective utilisation of the new capacities," Soi stated. Shares of the company were trading 0.24 per cent up at ₹ 1,265 apiece on BSE.

Star Imaging IPO allotment date likely today. Latest GMP, steps to check share allotment status online of SME IPO
Star Imaging IPO allotment date likely today. Latest GMP, steps to check share allotment status online of SME IPO

Mint

time20 minutes ago

  • Mint

Star Imaging IPO allotment date likely today. Latest GMP, steps to check share allotment status online of SME IPO

Star Imaging IPO Allotment: The initial public offering (IPO) of healthcare company Star Imaging & Path Lab Ltd ended with a decent subscription. As the bidding period has closed, focus shifts towards Star Imaging IPO allotment date. The public issue was open from August 8 to August 12. Star Imaging IPO allotment date is likely today, 13 August 2025, and the IPO listing date is August 18. Star Imaging IPO is an SME IPO and the equity shares of the company will be listed on BSE SME. The company will finalise the Star Imaging IPO allotment status soon. As soon as the basis of share allotment is fixed, the company will then credit the equity shares into the demat accounts of eligible allotment holders on August 14 and initiate refunds to unsuccessful bidders on the same day. Investors can check Star Imaging IPO allotment status online through the websites of BSE and IPO registrar. Kfin Technologies is the Star Imaging IPO registrar. In order to do Star Imaging IPO allotment status online check, investors must follow a few simple steps mentioned below: Step 2] Select 'Equity' in the Issue Type Step 3] Choose 'Star Imaging & Path Lab Limited' in the Issue Name dropdown menu Step 4] Enter either Application No. or PAN Step 5] Verify by ticking on 'I am not robot' and click on 'Search' Your Star Imaging IPO allotment status will be displayed on the screen. Step 1] Visit IPO registrar's website on this link - Step 2] Choose 'Star Imaging & Path Lab Limited' in the Select IPO dropdown menu Step 3] Select either Application No, Demat Account, or PAN Step 4] Enter the details as per the option selected Step 5] Enter the Captcha code and click on Submit Your Star Imaging IPO allotment status will be displayed on the screen. Star Imaging shares are showing a muted trend in the unlisted market with a little grey market premium (GMP). According to market experts, Star Imaging IPO GMP today is ₹ 3 per share. This means in the grey market, Star Imaging & Path Lab shares are trading higher by ₹ 3 apiece than their issue price. Star Imaging IPO GMP today signals that the estimated listing price of the stock would be ₹ 145 apiece, which is at 2% premium to the IPO price of ₹ 142 per share. The bidding for the SME IPO opened on August 8, and closed on August 12. Star Imaging IPO allotment date is likely today, August 13, and the IPO listing date is August 18. Star Imaging shares will be listed on BSE SME. The company raised ₹ 69.47 crore from the book-building issue which was a combination of fresh issue of 39 lakh equity shares aggregating to ₹ 55.66 crore and offer for sale of 10 lakh shares worth ₹ 13.80 crore. Star Imaging IPO price band was set at ₹ 135 to ₹ 142 per share. Star Imaging IPO was subscribed 5.67 times in total. The retail segment was subscribed 2.32 times, and the Qualified Institutional Bidders (QIB) category was booked 12.85 times. The Non-Institutional Investors (NII) segment received 4.38 times subscription. Share India Capital Services Pvt. Ltd. is the book running lead manager and Kfin Technologies is the Star Imaging IPO registrar.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store